US2021382033A1PendingUtilityA1
Single Molecule Proteomics
Est. expiryJul 25, 2034(~8 yrs left)· nominal 20-yr term from priority
Inventors:Kalim Mir
G16B 30/00G01N 2458/00G01N 33/58G01N 33/48721G01N 21/6486G01N 33/6842G01N 33/6803G01N 33/582G16B 20/00
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure comprises devices and methods for determining the identity of individual protein molecules in a complex mixture by unfolding the protein into a polypeptide, tagging selected residues on the polypeptide with selected oligonucleotide sequence tags that recognize selected residues on said polypeptide, and then detecting the oligonucleotide sequence tags.
Claims
exact text as granted — not AI-modified1 . A method for analyzing a protein, the method comprising:
i. unfolding a protein into a polypeptide; ii. tagging said polypeptide with reagents that recognize specific residues on said polypeptide; iii. rendering the polypeptide such that the distance between tag sites along the polypeptide is determined via the time elapsed between detection of tags; and iv. detecting the tags.
2 . The method of claim 1 , wherein step iii is performed before step ii.
3 . The method of claim 1 , wherein step ii is performed before step iii.
4 . The method according to claim 1 where the unfolding is conducted via a, mechanical, chemical or enzymatic method or a combination thereof.
5 . The method according to claim 1 where the unfolding is facilitated by a molecular motor comprising ClpX, ClpXP
6 - 9 . (canceled)
10 . The method according to claim 1 , wherein the tagging is conducted by chemical or biological means.
11 . The method according to claim 10 , wherein the tagging is performed using, NHS ester, malemide, or nickel-histidine chemistry.
12 . The method according to claim 10 where the tagging is performed using antibodies, affybodies, or aptamers.
13 . The method according to claim 10 , wherein the tagging comprises associating the polypeptide with a detectable label.
14 . The method according to claim 13 , wherein detectable label comprises a fluorescent/luminescent label, a light scattering label, a contrast label, size label or a nanoparticle label.
15 . A method for analyzing a protein, the method comprising:
i. unfolding a protein into a polypeptide ii. rendering the polypeptide such that the location, distance between and/or order of sites of choice along the polypeptide is resolvable by detecting features of the polypeptide along its length; and iii. detecting features of the polypeptide along the polypeptide length.
16 . The method according to claim 1 , wherein the polypeptide is passed linearly through a nano-constriction/gap or nanopore.
17 . The method according to claim 1 , wherein the features along the length are detected by perturbation of the interaction of two or more entities comprising FRET, RET, electron tunneling/transfer donor and acceptor or semi-conductor source and drain.
18 - 19 . (canceled)
20 . The method according to claim 15 , wherein the tag sites along the polypeptide are resolved by nanopore/nanogap detection.
21 - 23 . (canceled)
24 . The method according to claim 1 , wherein the specific residues are detected by optical microscopy, Raman spectroscopy, SERS/SERRS, lens-free microscopy, X-ray microscopy, electron microscopy, scanning probe microscopy, nanopore/nanogap detection, or near-field optical detection.
25 - 39 . (canceled)
40 . The method according to claim 1 , wherein the polypeptide is fused with a molecule, not comprising amino acids, prior to rendering the polypeptide such that the distance between tag sites along the polypeptide is determined via the time elapsed between detection of tags.
41 - 42 . (canceled)
43 . A method according to claim 40 , wherein the molecule, not comprising amino acids, comprises a cholesterol.
44 - 47 . (canceled)
48 . A device for carrying out the method according to 1 , the device comprising a macro interface, a microscale portion configured for containing ligands or for receiving ligands from an external reservoir, and a nanoscale portion configured for detecting or analyzing linear polypeptides.
49 - 53 . (canceled)
54 . The method according to claim 15 , wherein the polypeptide is passed linearly through a nano-constriction/gap or nanopore.
55 . The method according to claim 15 , wherein the features along the length are detected by perturbation of the interaction of two or more entities comprising FRET, RET, electron tunneling/transfer donor and acceptor or semi-conductor source and drain.Join the waitlist — get patent alerts
Track US2021382033A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.